Our sectors

We treat all personal data in accordance with our privacy policy.

Allergan breast implant claims

In December 2018, Allergan textured breast implants were removed from the market in Europe due to them being linked to a rare form of cancer called Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL).

Reported symptoms tend to describe a late onset of painful swollen breasts with a fluid collection usually between three and 14 years after implantation. Although investigations into the pathology of BIA-ALCL continue, positive outcomes have been reported and in most cases patients have achieved complete remission.

Understandably, many women who have or have had Allergan breast implants are concerned about whether they are at risk of contracting BI-ALCL. Leigh Day is investigating potential legal claims for those affected by these implants. 

If you have been affected by Allergan breast implants and would like to register your concern with us, please sign up here.
Register your interest

Share this page: Print this page